Astellas Pharma ADR (ALPMY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 03/31
| 12-2014 | 09-2014 | 06-2014 | 03-2014 | 12-2013 | |
| Sales | 3,153,040 | 2,873,280 | 2,892,539 | 0 | 0 |
| Cost of Goods | 883,520 | 797,760 | 744,633 | N/A | N/A |
| Gross Profit | 2,269,520 | 2,075,520 | 2,147,905 | N/A | N/A |
| Operating Expenses | 1,756,120 | 1,572,280 | 1,652,992 | 0 | 0 |
| Operating Income | 514,800 | 504,960 | 495,537 | N/A | N/A |
| Interest Expense | 880 | 6,720 | 20,698 | 0 | 0 |
| Other Income | 4,400 | 4,800 | 17,885 | 0 | 0 |
| Pre-tax Income | 518,320 | 503,040 | 492,724 | 0 | 0 |
| Income Tax | 124,960 | 175,680 | 141,287 | N/A | N/A |
| Net Income Continuous | 393,360 | 327,360 | 351,438 | N/A | N/A |
| Net Income | $394,240 | $327,360 | $351,438 | $N/A | $N/A |
| EPS Basic Total Ops | 0.18 | 0.15 | 0.16 | N/A | N/A |
| EPS Basic Continuous Ops | 0.18 | 0.15 | 0.16 | N/A | N/A |
| EPS Diluted Total Ops | 0.18 | 0.15 | 0.16 | N/A | N/A |
| EPS Diluted Continuous Ops | 0.18 | 0.15 | 0.16 | N/A | N/A |
| EBITDA(a) | $635,264 | $654,250 | $646,986 | $N/A | $N/A |